Your session is about to expire
← Back to Search
Herbal Medicine
Chinese herbs formula: Shu Yu Wan for Non-Small Cell Lung Cancer (CH:II Trial)
N/A
Waitlist Available
Research Sponsored by Lady Davis Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 weeks
Awards & highlights
CH:II Trial Summary
This study is evaluating whether Chinese Herb supplements lead to a measurable improvement in symptoms commonly experienced by patients with advanced stage lung cancer and an improvement in quality of life.
CH:II Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Physical Well-Being Scores at Baseline and 6 Weeks
Secondary outcome measures
Fatigue scores at Baseline and 6 weeks
CH:II Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Chinese herbs formula: Shu Yu WanExperimental Treatment1 Intervention
Participants will receive Shu Yu Wan capsules, to take 3 times daily for 6 weeks.
Group II: PlaceboPlacebo Group1 Intervention
Participants will receive capsules to take 3 times daily for 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Chinese herbs formula: Shu Yu Wan
2015
N/A
~20
Find a Location
Who is running the clinical trial?
Lady Davis InstituteLead Sponsor
44 Previous Clinical Trials
5,520 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger